期刊文献+

提高血清维生素D水平对良性阵发性位置性眩晕复发的影响 被引量:8

Increase serum vitamin D levels in preventing the recurrence of benign paroxysmal positional vertigo
在线阅读 下载PDF
导出
摘要 目的探讨提高血清维生素D水平在预防良性阵发性位置性眩晕(BPPV)复发中的价值。方法将120例于2013年1月-2014年12月期间在宝鸡市中心医院老年病科接受Epley手法复位治疗后的合并维生素D缺乏症的BPPV患者随机分为维生素D治疗组(60例)和无维生素D治疗的对照组(60例),并在开始维生素D治疗后1个月、2个月和6个月检测患者的血清25羟维生素D水平和判断BPPV复发与否,平治疗效果。结果两组患者在接受治疗前的血清25羟维生素D水平无明显差异(10.8±4.3 vs 10.6±4.3,P=0.792)。治疗组患者在接受维生素D治疗2个月后的血清25羟维生素D升高至参考范围(>30 ng·mL-1),并在6个月内维持正常水平,而对照组患者仍处于维生素D缺乏状态。在6个月的随访期内,治疗组患者的复发率仅为3.3%,而对照组患者的复发率达30.0%(P<0.001),两组患者间BPPV复发率的比值比OR=0.080(95%CI:0.017~0.363,P=0.001)。结论提高血清维生素D水平能够有效减少合并维生素D缺乏症的BPPV患者的复发率。 Objective To assess the clinical efficiency of increaseing serum vitamin D levels on preventing the recurrence of benign paroxysmal positional vertigo( BPPV). Method One hundred and twenty cases of BPPV patients complicated with vitamin D deficiency, who were treated with epley maneuver during January 2013 to December 2014 in our department, were randomly divided into two groups based on whether received vitamin D supplemental treatment: vitamin D treatmen group and control group. All patients were followed at 1 month, 2 months and 6 months after vitamin D treatment by detecting serum 25-hydroxy vitamin D( 25-OHD) level and aseessing the recurrence of BPPV. Results The baseline serum 25-OHD level before treatment was similar between two groups (10.8±4.3 vs 10.6±4.3, P=0.792). At month 2 of vitamin D treatment, serum 25-OHD in the treatment group increased significantly to normal level(>30 ng·mL^-1) and maintained in 6 months, whereas serum 25-OHD in the control group remained unchanged. During the 6 months follow up, the recurrence rate of BPPV in treatment group was 3.3%, but pretty higher in control groups( 30.0%). Qualitative variables analysis between two groups confirmed the oddi ratio was( OR=0.080, 95% CI: 0.017-0.363, P=0.001). Conclusion increasing serum vitamin D levels could significantly reduce the recurrence of BPPV.
作者 杜恒 薛挺 Du Heng;Xue Ting(Department of Geriatrics,the Baoji Central Hospital,Shanxi 721000,China)
出处 《脑与神经疾病杂志》 2019年第5期305-308,共4页 Journal of Brain and Nervous Diseases
关键词 良性阵发性位置性眩晕 维生素D 复发 Benign paroxysmal positional vertigo Vitamin D Recurrence
  • 相关文献

参考文献4

二级参考文献37

  • 1无.良性阵发性位置性眩晕的诊断依据和疗效评估(2006年,贵阳)[J].中华耳鼻咽喉头颈外科杂志,2007,42(3):163-164. 被引量:776
  • 2von Brevern M, Radtke A, Lezius F, et al. Epidemiology of benign paroxysmal positional vertigo: a population based study. J. Neurol. Neurosurg. Psychiatry.2007;78 ( 7 ) :710-715.
  • 3Epley JM. New dimensions of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg. 1980;88(5):599-605.
  • 4Schuknecht HF, Ruby RF. Cupulolithiasis. Adv Otorhinolaryngol. La- ryngoscope. 2013 Nov;123(11):2834-9 Laryngoscope. 2013 Nov;123 (11):2834-2839.
  • 5Imai T1, Takeda N, Ito M, Inohara H. Natural course of p Laryngo- scope. 2013 Nov;123(11):2834-2839.
  • 6Zucca G, Valli S, Valli P, et al.Why do benign paroxysmal positional vertigo episodes recover spontaneously? J Vestib Res. 1998;8(4): 325-329.
  • 7Parham K1, Leonard G, Feinn RS, Lafreniere D, Kenny AM. Prospec- tive clinical investigation of the relationship between idiopathic be- nign paroxysmal positional vertigo andbone turnover: a pilot study. Laryngoscope. 2013;123(11):2834-2839.
  • 8Korres SG, Balatsouras DG. Diagnostic, pathophysiologic, and thera- peutic aspects of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg,2004; 131 (4):438-444.
  • 9Moon SY, Kim JS, Kim BK et al.Clinical characteristics of benign paroxysmal positional vertigo in Korea: a multicenter study. J Kore- an Med Sci.2006;21(3):539-543.
  • 10Yagi T, Koizumi Y, Kimura M, et al.Pathological localization of so-called posterior canal BPPV. Auris Nasus Larynx. 2006;33(4): 391-395.

共引文献843

同被引文献79

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部